DYN earnings: a negative outcome, -6.6%

On March 5, 2024, Dyne Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.6% in the window around the event. It had already run +38.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.